EA202090151A1 - APPLICATION OF INHALED NITROGEN OXIDE (II) FOR TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH A LUNG DISEASE - Google Patents
APPLICATION OF INHALED NITROGEN OXIDE (II) FOR TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH A LUNG DISEASEInfo
- Publication number
- EA202090151A1 EA202090151A1 EA202090151A EA202090151A EA202090151A1 EA 202090151 A1 EA202090151 A1 EA 202090151A1 EA 202090151 A EA202090151 A EA 202090151A EA 202090151 A EA202090151 A EA 202090151A EA 202090151 A1 EA202090151 A1 EA 202090151A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pulmonary hypertension
- treatment
- lung disease
- application
- nitrogen oxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
В заявке описаны способы применения вдыхаемого оксида азота (II) для лечения легочной гипертензии и/или улучшения насыщения кислородом у пациента с несоответствием вентиляции-перфузии (V/Q) и/или легочной гипертензии, связанной с заболеванием легких.The application describes methods of using respirable nitric oxide (II) for the treatment of pulmonary hypertension and / or improving oxygen saturation in a patient with a mismatch of ventilation-perfusion (V / Q) and / or pulmonary hypertension associated with lung disease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762611325P | 2017-12-28 | 2017-12-28 | |
PCT/US2018/048526 WO2019046415A1 (en) | 2017-08-30 | 2018-08-29 | Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202090151A1 true EA202090151A1 (en) | 2020-06-19 |
Family
ID=71138796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202090151A EA202090151A1 (en) | 2017-12-28 | 2018-08-29 | APPLICATION OF INHALED NITROGEN OXIDE (II) FOR TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH A LUNG DISEASE |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202090151A1 (en) |
-
2018
- 2018-08-29 EA EA202090151A patent/EA202090151A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500197A1 (en) | Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease | |
EA202091286A1 (en) | APPLICATION OF INHALED NITROGEN (II) OXIDE AND OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION | |
EA202091288A1 (en) | PULSE INHALED NITROGEN OXIDE (II) FOR THE TREATMENT OF PULMONARY HYPERTENSION | |
CY1122292T1 (en) | COMPOUNDS AND METHODS FOR ANTIAL TREATMENT | |
BR112018011803A2 (en) | method and mechanism for gas administration including nitric oxide | |
PH12017502103A1 (en) | Methods and kits for treating depression | |
MX2017015473A (en) | Treatment of cancer by manipulation of commensal microflora. | |
MX2023000796A (en) | Pharmaceutical composition, methods for treating and uses thereof. | |
CA2837341C (en) | Method of determining vasoreactivity using inhaled nitric oxide | |
MX2018015089A (en) | Combinations of linagliptin and metformin. | |
EA202191556A1 (en) | COMBINED THERAPY WITH RADIO IMMUNOCONJUGATES AND CONTROL POINT INHIBITORS | |
MX2021008418A (en) | Combination drug therapies of pde-5 inhibitors and inhaled nitric oxide. | |
EA201991175A1 (en) | THE USE OF INTERFERON-LAMBDA IN MEDICINE FOR THE TREATMENT OF FIBROSIS | |
NZ736807A (en) | Gata-3 inhibitors for use in the treatment of th2-driven asthma | |
CY1125307T1 (en) | METHOD OF TREATMENT OF PATIENTS WITH RIVAROXAMPAN AND VERAPAMIL ADMINISTRATION | |
DK3615034T3 (en) | RUCAPARIB, TALAZOPARIB, VELIPARIB, OLAPARIB AND AZD 2461 FOR THE TREATMENT OF DETERIORATED SKIN WOOL | |
PH12017500505A1 (en) | Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers | |
EA201892280A1 (en) | METHODS OF TREATMENT BY SELECTIVE AGONISTS OF CB-RECEPTOR | |
EA202091781A1 (en) | BINDING MOLECULE WITH NEUTRALIZING ACTIVITY AGAINST THE MIDDLE EASTERN RESPIRATORY CORONAVIRUS | |
MX2020002744A (en) | Methods and compositions for treating chronic lung diseases. | |
EA202090151A1 (en) | APPLICATION OF INHALED NITROGEN OXIDE (II) FOR TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH A LUNG DISEASE | |
WO2018045371A3 (en) | nNIF AND nNIF-RELATED PEPTIDES AND RELATED METHODS | |
BR112019001134A2 (en) | use of lactam and pharmaceutical composition | |
EA202190504A1 (en) | METHODS FOR TREATMENT OF PSORIASIS | |
EA201991119A1 (en) | PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND ITS APPLICATION |